We offer patients emerging treatments for macular diseases.
Browse a list of current, upcoming and previous clinical trials conducted through the Clinical Research Unit.
| Trial | Condition | Details |
|---|---|---|
| Star-MOG (opening soon) | Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease | Ethics approval RPAH 2024/ETH02047 |
| Encelto (opening soon) | MacTel Type II | Ethics approval SVHM 104/25 & SCHN 2025/ETH01223 |
| Hyperion (opening soon) | Leber Congential Amaurosis (LCA) | Ethics approval SVHM 104/25 & SCHN 2025/ETH01223 |
| Therini DME | Diabetic Macular Oedema | Ethics approval Bellberry 2025/ETH00734 |
| Biocryst | Diabetic Macular Oedema | Ethics approval Bellberry 2025/ETH00954 |
| KLARITY | Central Macular Oedema | Find out more Ethics approval SVHM HREC 309/24 |
| iSight-2 | Dry AMD to late Dry AMD | Ethics approval Bellberry 2024/ETH02730 |
| Vantage | Non -proliferative Diabetic Retinopathy | Ethical approval SVHM HREC 250/24 |
| BenoBio | Wet AMD | Ethical approval Bellberry HREC 2024/ETH01779 |
| RADAR | Diabetic Eye Disease | Ethical approval HREC/13/SAC/92 |
| MacTel Project | MacTel | Ethical approval HREC/16/POWH/215 |
"I was so happy with the whole team's service and with how kind everyone was at every visit. It felt like family and 'home'. "
“I feel very honoured to be part of clinical trials helping find new medications for future patients...the research team provides a very high level of service to the patients involved.”
“My experience with the clinical trials team has been very good and I am very appreciative of the support that I received throughout my time with them.”
Hear more from our patients here.
